Esperion Therapeutics | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
AbbVie USD 4.81B 1.54B 2024-12
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amarin USD -13630000 197K 2025-03
Amgen USD 3.38B 111M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Cipla INR 15.04B 4.12B 2025-03
CSL USD 2.54B 1.34B 2024-12
Cytokinetics USD -161376000 11.36M 2025-03
Daiichi Sankyo JPY 80.63B 1.78B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Geron USD -19835000 5.52M 2025-03
Grifols 66.98M 19.92M 2024-06
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
Ionis Pharmaceuticals USD -147000000 40M 2025-03
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Sanofi EUR 2.16B 20M 2025-03
Sarepta Therapeutics USD -383518000 555.26M 2025-03
United Therapeutics USD 423.5M 27M 2025-03



Esperion Therapeutics L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.